Itraconazole treatment of coccidioidomycosis

The American Journal of Medicine

Volumn 89, Issue 3, 1990, Pages 282-290

  Graybill, John R ^a   Stevens, David A ^a   Galgiani, John N ^a   Dismukes, William E ^a   Cloud, Gretchen A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC LUNG DISEASE; COCCIDIOIDOMYCOSIS; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FUNGUS; HUMAN; HYPERTENSION; HYPOKALEMIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHROPATHY; PHOTOPHOBIA; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; SOFT TISSUE DISEASE; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; BONE DISEASES; COCCIDIOIDOMYCOSIS; DERMATOMYCOSES; DRUG RESISTANCE, MICROBIAL; FEMALE; FOLLOW-UP STUDIES; HUMAN; ITRACONAZOLE; JOINT DISEASES; KETOCONAZOLE; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGE; RECURRENCE; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025082734     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(90)90339-F     Document Type: Article

References (30)

1. State of the art: coccidioidomycosis: part II
2. Antifungal agents used in systemic mycoses: activity and therapeutic use
3. Amphotericin B in the treatment of coccidioidomycosis
4. Ketoconazole in the treatment of coccidioidomycosis
5. Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis
6. Ketoconazole therapy for systemic mycotic infections: inadequacy of standard dosage regimens
7. Treatment of fungal infections in bone and joints with ketoconazole
8. Ketoconazole treatment of non-primary coccidioidomycosis
9. Ketoconazole for treatment of disseminated coccidioidomycosis
10. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients
11. Ketoconazole therapy of progressive coccidioidomycosis
12. Pharmacology and toxicity of high dose ketoconazole
13. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action
14. Itraconazole: pharmacologic studies in animals and humans
15. Treatment of mycoses with itraconazole
16. The use of immunodiffusion tests in coccidioidomycosis. I. The accuracy and reproductability of the immunodiffusion test which correlates with complement fixation
17. Nonparametric estimation from incomplete observations
18. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs
19. Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients
20. Therapeutic evaluation of ketoconazole in patients with coccidioidomycosis
21. Chapter XIV: Coccidioidomycosis
22. High dose itraconazole in the treatment of severe mycoses
23. Ketoconazole blocks adrenal steroid synthesis
24. High-dose ketoconazole therapy and adrenal and testicular function in humans
25. Reversible adrenal insufficiency induced by ketoconazole
26. Adrenal response to corticotropin during therapy with itraconazole
27. Toxic hepatitis during ketoconazole treatment
28. Hepatitis and ketoconazole therapy
29. Hepatic reactions during ketoconazole treatment
30. Itraconazole in the treatment of human mycoses: review of three years of clinical experience